260 Impact of BRCA & PD-L1 in EOC Patients Receiving Standard 1st Line Therapy +/- Pembrolizumab: Exploratory Analyses from the NeoPembrOV Study (GINECO)O Le Saux,AM Savoye,MA Mouret-Reynier,C Schiffler,O Derbel, T Isabelle,E Kalbacher, S Gouerant,A Martinez, C Cornila,M Martinez,L Bengrine Lefevre,F Priou,N Cloarec,L Venat-Bouvet,A Angelergues,D Berton,O Collard,E Coquan,I Ray-CoquardOvarian cancer（2021）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
